Guru Ownership Trend
Guru Analysis for Spyre Therapeutics, Inc. (SYRE)
Spyre Therapeutics, Inc. (SYRE), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 2 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $35.54 M.
Top institutional holders include Steven Cohen and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $26.98 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Spyre Therapeutics, Inc. (SYRE)
Major holders include Steven Cohen ($31.78 M), Cliff Asness ($2.08 M). According to the latest reported data, 2 tracked investment managers collectively hold approximately 380,231 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $26.98 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited SYRE. The total reported sell value was $4.83 M.
Yes, 1 managers opened new positions in SYRE, and 1 increased their existing holdings. The total reported buy value was $31.81 M.